In a previous article, we provided a list of 7 publicly traded companies involved in the RNAi Therapeutics space. With the recent IPO of Mirna Therapeutics (NASDAQ:MIRN) and the Benitec listing ADR listing (NASDAQ:BNTC), we can now rebalance our original RNAi therapeutics portfolio for a total of 9 stocks as seen below: When creating this portfolio, […]
When it comes to promising disruptive technologies, synthetic biology has to be in the top-5. The ability to create artificial living organisms that perform a wide range of useful tasks is an incredibly powerful thing. Perhaps the most talked-about synthetic biology stock right now is Intrexon (NYSE:XON) and with a market cap today of over $4.93 billion, […]
We’ve written quite a few articles about synthetic biology stock Intrexon (NYSE:XON) which has performed strongly since their IPO returning +68% to date. Recently though, XON hasn’t performed well with the stock now down -25% in the past five days and down -15% in yesterday’s trading session on the back of their first-half 2015 results. […]
Ever since the first artificial life was created using synthetic biology, the technology is seen to hold great potential with promises of everything from genetically engineered plants and animals, to customized microorganisms that can be programmed to produce high-value chemicals from basic feedstocks. While synthetic biology darling Intrexon’s stock continues to reach new highs, not […]
Graphene is an exciting material, make no mistake. When investors read about the potential applications for this miracle nanomaterial, they want in on the ground floor and look for companies that can give them pure play exposure to the graphene theme. However, caution is warranted. Some companies purport to be in the graphene business but […]
In an article last week we discussed some of the setbacks that 3 publicly traded synthetic biology companies are going through in an attempt to use modified organisms to produce various chemicals and fuels. After some initial setbacks that haven’t been too kind to investors, it seems that each of these 3 companies is trying […]
Graphene is a material with remarkable properties that has attracted the attention of starry-eyed investors who are dreaming up all kinds of potential disruptive applications such as advanced materials, solar cells, touch screens, and 3D printing. Quite a number of “graphene producing” startups have popped up including the first graphene IPO last year from Applied Graphene Materials […]
Synthetic biology is a rapidly growing field of interest to investors in multiple industries such as pharmaceuticals and energy. In 2010, an organism was created by Synthetic Genomics which was the first self-replicating species on the planet which had its biological recipe created by a computer. This was the first recorded instance of mankind creating artificial life. The […]
In Q1 of 2014, we highlighted a very exciting company called Synthetic Genomics which was founded in 2005 by Craig Venter. Mr. Venter previously founded The Institute for Genomic Research (TIGR), the J. Craig Venter Institute (JCVI), and genetic sequencing company Celera Corporation which was acquired by Quest Diagnostics (NYSE:DGX) in 2011 for about $650 million. Mr. Venter was one […]
Quantum dots are tiny bits of semiconductor crystals that are less than 10 nanometers in size. These nanomaterials exhibit remarkable properties that open up a broad array of applications such as biological tagging, LEDs, displays, and even solar cells. Nanoco (LON:NANO) first came across our radar a few years ago as the only publicly traded pure play company for […]